Regulatory feed
Published med-spa & injectable compliance alerts · monitoring, not legal advice
Free weekly Brief
Get the changes that matter in plain English, every week — and be alerted when the rules move. No charge.
Members get the full “what to do” on every alert — in real time, for your states. Become a member →
Border enforcement · last 90 days
FDA Import Refusals · counts of published records
FDA refused 108 shipments of unapproved or violative injectables at the U.S. border from 73 firms across 23 countries — the gray-market corridor to source away from.
| Product class | Shipments | Firms | Countries |
|---|---|---|---|
| Dermal fillersincl. Across Co., Ltd, LABORTORIES FILLMED, Dongkook Pharmaceutical Co., Ltd. | 54 | 37 | 12 |
| Botulinum toxinincl. Allergan Pharmaceuticals Ireland, Medytox Inc., Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) | 29 | 16 | 8 |
| GLP-1 drugsincl. NGUYEN VIET ANH - CCCD#035094002294, Eli Lilly Japan K.K.Seishin Laboratories, CHONGUHAN MEDICAL TECHNOLOGIES | 14 | 13 | 9 |
| Injectable anestheticsincl. SELECTPHAMA, Vivozon Pharmaceutical, LABORATORIO PIERSAN S.A. | 11 | 11 | 6 |
Source: FDA Data Dashboard import refusals. A refusal is a border action, not a finding against any U.S. practice. Named firms are the foreign shippers/manufacturers on FDA’s record.
Showing everything, including routine background items (bulk import refusals, inspection citations).
Show material only →- MONITORFEDAesthetic InjectablesAug 6, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA denies entry of foreign collagen implants for aesthetics.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Across Co., Ltd · Chuncheon-si · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIAug 4, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
OnabotulinumtoxinA from Ireland refused entry to the US.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused as unapproved new drug · FDA lab-analyzed
- MONITORFEDAesthetic InjectablesAug 4, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
Collagen implants from France denied entry to the US by FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · LABORTORIES FILLMED · Paris-L'Hopital · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesFDA: VAIAug 3, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
FDA refuses entry of injectable product ONABOTULINUMTOXINA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused entry by FDA · FDA lab-analyzed
- MONITORFEDAesthetic InjectablesAug 3, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of dermal collagen imports from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · SEORIN COMPANY CO LTD · Chuncheon · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesAug 3, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refused shipment of OnabotulinumtoxinA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Medytox Inc. · Cheongju · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesAug 3, 2026
FDA import refusal: Solution, Sodium Hyaluronate (South Korea)
FDA refuses entry for sodium hyaluronate from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Dongkook Pharmaceutical Co., Ltd. · Seoul · medical device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 31, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry for collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · WEDERM · Seoul · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesFDA: VAIJul 31, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
FDA refuses entry of onabotulinumtoxinA from Ireland.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIJul 31, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses OnabotulinumtoxinA shipment from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) · Hwaseong · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 31, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refuses entry of dermal collagen implants from Sweden.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingJul 31, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (Vietnam)
FDA refuses entry of Tirzepatide from Vietnam; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · NGUYEN VIET ANH - CCCD#035094002294 · Hanoi Center · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJul 31, 2026
FDA import refusal: Lidocaine (Guatemala)
Lidocaine from Guatemala refused entry by FDA; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · SELECTPHAMA · Mixco · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIJul 31, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use
FDA refuses entry of collagen implants for aesthetic use.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Revance Therapeutics, Inc · Newark · plastic-surgery device · refused as misbranding
- MONITORFEDGLP-1 CompoundingJul 30, 2026
FDA / Federal Register Notice: Outsourcing Facility Fee Rates for Fiscal Year 2027
New FDA fees for outsourcing facilities will impact med spas using compounds.
What to do — members only.Become a member →Federal Registerprimary source ↗ - MONITORFEDAesthetic InjectablesJul 29, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Pharmaresearch · Gangneung-si · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingJul 27, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (Japan)
FDA blocks tirzepatide shipment from Japan – verify your suppliers!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Eli Lilly Japan K.K.Seishin Laboratories · Nishigun · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJul 27, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry of ONABOTULINUMTOXINA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Meditox Co. · Heungdeok-gu · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesFDA: VAIJul 27, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses import of OnabotulinumtoxinA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Hugel Inc. · Chuncheon · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 27, 2026
FDA import refusal: Lidocaine (South Korea)
FDA refuses entry of lidocaine from South Korea; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Vivozon Pharmaceutical · Hwaseong · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 27, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry for a collagen implant from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ACROSS CO LTD · Chuncheon-Si · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 27, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry of ONABOTULINUMTOXINA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · PharmaResearch BIO Co., Ltd. · Gangreung · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesFDA: VAIJul 27, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry of injectable product from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) · Hwaseong · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 27, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of dermal collagen implant from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · BioPlus Co.,Ltd. · Seongnam · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 25, 2026
FDA import refusal: Acid, Hyaluronic, Intraarticular (Sweden)
FDA refuses entry of hyaluronic acid from Sweden for unknown violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-MED AB · Sweden · medical device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Vietnam)
FDA refuses entry of OnabotulinumtoxinA from Vietnam; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · TRAN THI THU HIEN · Ha Noi City · drug product · refused entry by FDA
- MONITORFEDGLP-1 CompoundingFDA: VAIJul 24, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (Denmark)
FDA refused entry of semaglutide from Denmark.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Novo Nordisk A/S · Bagsvard · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIJul 24, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Germany)
FDA refuses entry for OnabotulinumtoxinA from Germany.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz Pharma Gmbh & Co. KGaA · Reinheim · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses shipment of collagen implant from France.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Industrie SAS · Pringy · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry for dermal collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Pharmaresearch · Gangneung-si · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: VAIJul 24, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (United Kingdom)
FDA refuses ONABOTULINUMTOXINA import; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Ipsen BioPharm Ltd · Wrexham · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Switzerland)
FDA refuses entry of collagen dermal implants from Switzerland.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Teoxane S.A. · Geneva · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry of French collagen implant for aesthetics.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ALLERGAN · Annecy · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Lidocaine (China)
FDA refuses lidocaine shipment from China due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Shaanxi Bieyouth Biotech Co.,Ltd · Xian · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Triamcinolone Acetonide (Glucocorticoid) (Guatemala)
FDA refuses Guatemala-sourced triamcinolone acetonide shipment.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · LABORATORIO PIERSAN S.A. · Cdad · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Austria)
FDA refuses entry of collagen implants from Austria; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CROMA-PHARMA GMBH · Leobendorf · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingJul 24, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (China)
FDA rejects tirzepatide shipment from China due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CHONGUHAN MEDICAL TECHNOLOGIES · Guangzhou · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refused entry of collagen implants from Sweden; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA rejects botulinum toxin import from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · PharmaResearch BIO Co., Ltd. · Gangreung · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA blocks import of dermal collagen from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Forest Hills Lab Korea Co Ltd · Gyeonggi-do · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of aesthetic collagen implant from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · HNG Co., Ltd. · Seocho · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses shipment of aesthetic collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · SEORIN COMPANY CO LTD · Chuncheon · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: VAIJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use
Collagen implant shipment refused by FDA; verify your sources!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz North America, Inc. · Franksville · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Switzerland)
FDA refuses entry of dermal collagen implant from Switzerland.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ANTEIS SA · Plan-les-Ouates · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA blocks botulinum toxin from South Korea—verify your suppliers!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Meditox Co. Ltd. · Unknown · drug product · refused entry by FDA
- MONITORFEDGLP-1 CompoundingJul 22, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (India)
FDA rejects tirzepatide import from India; check your suppliers!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ELI LILLY AND COMPANY PVT LTD · Bhiwandi · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJul 22, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
FDA refuses entry of dermal collagen implant from Vietnam.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · TRAN THI THU HIEN · Ha Noi City · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: OAIJul 21, 2026
FDA import refusal: Lidocaine (Belgium)
FDA refuses entry of lidocaine from Belgium—check your suppliers!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Laboratoria Qualiphar NV · Bornem · drug product · refused as adulteration
- MONITORFEDAesthetic InjectablesJul 21, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
FDA rejects injectable collagen from Vietnam due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CHIAKI TRADING JSC · Hanoi City · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDGLP-1 CompoundingFDA: VAIJul 21, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (Denmark)
FDA rejects semaglutide shipment from Denmark; verify supplier sources.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Novo Nordisk A/S · Bagsvard · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJul 17, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Colombia)
FDA refuses entry of Colombian dermal collagen implant.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · GALDERMA DE COLOMBIA SA · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 16, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refuses entry of Swedish collagen implant for aesthetics.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIJul 16, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
FDA refuses entry of OnabotulinumtoxinA from Ireland.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 14, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
Important: FDA refuses dermal implant shipment from Sweden.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MARELI MEDICAL AB · Malmo · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingJul 13, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (United Kingdom)
FDA refuses entry of injectable Semaglutide from the UK.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ASIAN SUITS ONLINE LIMITED · Leicester · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesJul 11, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry for collagen dermal implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · SEORIN COMPANY CO LTD · Chuncheon · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 11, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry of collagen implants from France.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ALLERGAN · Annecy · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIJul 10, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses ONABOTULINUMTOXINA from South Korea; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) · Hwaseong · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesJul 10, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refuses entry of a dermal collagen implant from Sweden.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 10, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (India)
FDA rejects ONABOTULINUMTOXINA from India; check your supplier!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · HIMANI BIOSCIENCES · Solan · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJul 10, 2026
FDA import refusal: Botox (onabotulinumtoxinA)
FDA refuses entry of OnabotulinumtoxinA from Illinois due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · AbbVie Inc. · North Chicago · drug product · refused as unapproved new drug
- MONITORFEDGLP-1 CompoundingJul 10, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (Canada)
FDA refuses semaglutide shipment from Canada; avoid gray-market sources.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · NOVO NORDISK · Mississauga · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJul 10, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Italy)
FDA refuses entry for collagen implants from Italy; check your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · IBSA Farmaceutici Italia Srl · Lodi · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: VAIJul 10, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry of collagen implant from France; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Industrie SAS · Pringy · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 10, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Germany)
Injectable collagen implants from Germany denied entry by FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz Pharmaceuticals GmbH · Frankfurt Am Main · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 10, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Italy)
FDA refuses entry of Italian collagen implants—check your suppliers!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Mariior · Marignano · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 9, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of South Korean collagen dermal implants.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · BNC Global · Incheon · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIJul 8, 2026
FDA import refusal: Daxxify (daxibotulinumtoxinA)-LANM
FDA refuses entry for DAXIBOTULINUMTOXINA-LANM; avoid unverified sources.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Revance Therapeutics, Inc · Newark · drug product · refused entry by FDA
- CRITICALFEDGLP-1 CompoundingFDA: OAIJul 8, 2026
FDA Warning Letter: Spa De Soleil, Inc. (Drugs)
FDA warns Spa De Soleil over drug compounding practices.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFEDAesthetic InjectablesJul 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Brazil)
FDA refuses Brazilian collagen implant shipment.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Pharmaesthetics do Brasil Industria de Medicamentos LTDA · Zielonka · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry of overseas collagen implant.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Sinclair France SAS · Dardilly · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refuses entry of collagen implants from Sweden; heed sourcing warnings.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 8, 2026
FDA import refusal: Implant, Dermal, for Aesthetic Use in the Hands (Sweden)
FDA refuses dermal implant entry from Sweden—stay vigilant!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingJul 7, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (United Kingdom)
FDA refuses entry of TIRZEPATIDE from the UK; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ARAMEX- TRANSIT · Slough · drug product · refused as adulteration
- MONITORFEDAesthetic InjectablesJul 7, 2026
FDA import refusal: Solution, Sodium Hyaluronate (Paraguay)
Product shipment from Paraguay refused by FDA; heed sourcing warnings.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · FABIANO DA SILVA MATOS · Ciudad Del Este · medical device · refused as misbranding
- MONITORFEDAesthetic InjectablesFDA: VAIJul 6, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use
FDA refused entry of dermal collagen implants on July 6, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz North America, Inc. · Franksville · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 6, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry for collagen implants from France; verify suppliers!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan · Pringy 74370 Annecy · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 6, 2026
FDA import refusal: Lidocaine (Sweden)
FDA refuses entry of lidocaine shipment from Sweden.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MARELI MEDICAL AB · Malmo · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 5, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of injectable collagen from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · SEORIN COMPANY CO LTD · Chuncheon · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
FDA refuses shipment of collagen implant from Vietnam.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CHIAKI TRADING JSC · Hanoi City · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Lidocaine (India)
FDA refuses entry of lidocaine from India—check your suppliers!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ARISTO PHARMACEUTICALS · Mumbai · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Switzerland)
Imported collagen implants from Switzerland were refused by the FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · GALDERMA LABORATORIES · Lausanne · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: VAIJul 2, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (United Kingdom)
FDA bars entry of ONABOTULINUMTOXINA from the UK.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Ipsen BioPharm Ltd · Wrexham · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses OnabotulinumtoxinA shipment from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Medytox Inc. · Cheongju · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA denies entry to a dermal collagen implant from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · BioPlus Co.,Ltd. · Seongnam · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA rejects collagen implants from South Korea; check your sources.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · LG Chemical LTD. · Seoul · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses ONABOTULINUMTOXINA from South Korea; review your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Medytox Inc. · Cheongju · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Vietnam)
FDA refuses ONABOTULINUMTOXINA shipment from Vietnam.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · TRAN THI THU HIEN · Ha Noi City · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJun 30, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Vietnam)
FDA refuses entry of OnabotulinumtoxinA from Vietnam.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · HASAKI BEAUTY & CLINIC JSC · Hanoi City · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJun 30, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refuses entry of collagen implant from Sweden—stay cautious.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MARELI MEDICAL AB · Malmo · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingJun 30, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (China)
FDA refuses entry of semaglutide from China—stay compliant!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Hybio Pharmaceutical Co., Ltd. · Shenzhen · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesFDA: VAIJun 30, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (United Kingdom)
FDA refuses ONABOTULINUMTOXINA from overseas; verify your supplier.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Ipsen BioPharm Ltd · Wrexham · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIJun 29, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
FDA refuses ONABOTULINUMTOXINA entry from Ireland — verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: OAIJun 29, 2026
FDA import refusal: Lidocaine Hcl (Anesthetic) (India)
FDA refuses entry of Lidocaine HCl from India; stay cautious.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Mahendra Chemicals · Ahmedabad · drug product · refused as adulteration
- MONITORFEDAesthetic InjectablesJun 29, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA blocks import of a dermal collagen implant from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · LG Chem., Ltd. · Iksan · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesFDA: VAIJun 29, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry of French collagen implant due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Industrie SAS · Pringy · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJun 29, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
FDA blocks vital aesthetic product from Vietnam due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CHIAKI TRADING JSC · Hanoi City · plastic-surgery device · refused as adulteration
- MONITORFEDAesthetic InjectablesJun 29, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
Shipment of collagen implants from South Korea refused by FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Jemate · Gyeonggi-do · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJun 29, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Germany)
FDA refuses entry of German botulinum toxin; verify your suppliers!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz Pharmaceuticals GmbH · Frankfurt Am Main · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJun 29, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Turkey)
FDA refuses entry of OnabotulinumtoxinA from Turkey — stay alert!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ALLERGAN ILACLARI TICARET A.S. · Sariyer · drug product · refused as misbranding, unapproved new drug
- MONITORFEDGLP-1 CompoundingJun 29, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (India)
FDA refuses entry of semaglutide from India - verify your suppliers!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · NOVO NORDISK INDIA PRIVATE LIMIT · Bangalore · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJun 26, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · BNC INTERNATIONAL · Incheon · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIJun 26, 2026
FDA import refusal: Lidocaine (China)
FDA refuses lidocaine shipment from China due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Planet (Anhui) Pharmaceuticals Co., Ltd · Chuzhou · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesJun 26, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of foreign dermal implant; stay vigilant.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · HUGEL CO LTD · Gangnam · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingJun 26, 2026
FDA / Federal Register Notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period
FDA extends comment period on GLP-1 compounding decisions.
What to do — members only.Become a member →Federal Registerprimary source ↗ - MONITORFEDGLP-1 CompoundingJun 26, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (India)
FDA refuses entry of Semaglutide from India; verify suppliers!
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · AULI KRUPA · Mumbai · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJun 24, 2026
FDA import refusal: Lidocaine Hcl (Anesthetic) (South Korea)
FDA refuses shipment of Lidocaine HCL from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Huons Co., Ltd. · Jecheon · drug product · refused as adulteration
- MONITORFEDAesthetic InjectablesJun 24, 2026
FDA import refusal: Triamcinolone (Glucocorticoid) (Guatemala)
FDA rejects triamcinolone shipment from Guatemala.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Infasa · Mixco · drug product · refused as misbranding, unapproved new drug
- MONITORFEDGLP-1 CompoundingJun 23, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (Bangladesh)
FDA refuses TIRZEPATIDE import from Bangladesh; details pending.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Drug Internatinal Gazipur Bangladesh · Dhaka · drug product · refused as misbranding
- CAUTIONFEDGLP-1 CompoundingJun 23, 2026
FDA Warning Letter: ketaminelab.org (Drugs)
FDA Warning Letter issued to ketaminelab.org for drugs.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFEDAesthetic InjectablesFDA: VAIJun 23, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry of ONABOTULINUMTOXINA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Hugel Inc. · Chuncheon · drug product · refused entry by FDA
- MONITORFEDGLP-1 CompoundingFDA: OAIJun 22, 2026
FDA import refusal: Semaglutide (Anti-diabetic)
FDA refused entry of a semaglutide shipment due to violation.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Novo Nordisk Inc. · Plainsboro · drug product · refused as unapproved new drug
- CAUTIONFEDMarketing & AdvertisingJun 12, 2026
FTC Files Contempt Motion Against Amare Global and Three Individuals Over Unsubstantiated Health Claims
FTC targets deceptive health claims affecting aesthetic practices.
What to do — members only.Become a member →FTC Enforcementprimary source ↗ - CAUTIONFEDGLP-1 CompoundingJun 11, 2026
FDA shortage: Liraglutide Injection (Injection) — Currently in Shortage
Liraglutide remains in shortage; compounding is still permitted.
What to do — members only.Become a member →FDA Drug Shortagesprimary source ↗ - CRITICALFEDGLP-1 CompoundingMay 27, 2026
FDA recall (Class II): Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, Fl 34108, …
FDA recalls contaminated Liraglutide Injection; check your inventory!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORMAScope of PracticeMay 26, 2026
MA H5455: Regulating the operation of medical spas
New regulations on med spas in Massachusetts could change operations.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingMay 26, 2026
FDA / Federal Register Notice: Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
FDA seeks comments on human drug compounding regulations.
What to do — members only.Become a member →Federal Registerprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIMay 15, 2026
FDA inspection citations: Emcure Pharmaceuticals Limited (7 observations)
FDA cites Emcure Pharmaceuticals for sterile process issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIMay 15, 2026
FDA inspection citations: Unither Manufacturing LLC. (9 observations)
FDA cites Unither Manufacturing for issues related to sterility.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIMay 13, 2026
FDA inspection citations: InvaTech Pharma Solutions, LLC (6 observations)
Med spas should verify sourcing from InvaTech Pharma Solutions.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIMay 5, 2026
FDA inspection citations: Zydus Lifesciences Limited (7 observations)
FDA cites Zydus Lifesciences for sterility and quality issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIMay 4, 2026
FDA inspection citations: Element Materials Technology Boston - Acton Inc. (4 observations)
Caution urged for med spas sourcing from a cited facility.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIMay 1, 2026
FDA inspection citations: SnugZ USA, Inc. (9 observations)
FDA cites SnugZ USA for quality control issues; verify your supply.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingMay 1, 2026
FDA / Federal Register Notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act
FDA evaluates bulk drug substances; GLP-1 agents may be impacted.
What to do — members only.Become a member →Federal Registerprimary source ↗ - MONITORFEDGLP-1 CompoundingApr 30, 2026
FDA / Federal Register Notice: Determination That Ozempic (Semaglutide) Solution, 2 Milligrams Per 1.5 Milliliters Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
FDA ensures continued access to OZEMPIC for aesthetic practices.
What to do — members only.Become a member →Federal Registerprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIApr 29, 2026
FDA inspection citations: American Red Cross Manchester Fixed Site (1 observation)
FDA cites facility for sterility issues impacting med spas.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIApr 24, 2026
FDA inspection citations: Hanlim Pharm Co. Ltd. (11 observations)
FDA cites Hanlim Pharm for sterility and validation issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIApr 24, 2026
FDA inspection citations: University of Vermont Health Network - Adirondack Blood Center (2 observations)
FDA cites facility for sterility issues; verify your sources.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORCOMulti-topicApr 23, 2026
CO SB130: Medical Spas Deceptive Trade Practices
Colorado SB130 — pending bill on med-spa trade practices. Tracking.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingApr 22, 2026
FDA recall (Class II): Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Bea…
FDA recalls semaglutide compound over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIApr 21, 2026
FDA inspection citations: Altaire Pharmaceuticals, Inc. (8 observations)
Caution: FDA cites facility for sterility issues; verify your sources.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIApr 14, 2026
FDA inspection citations: Rohto-Mentholatum (Vietnam) Co., Ltd. (8 observations)
FDA cites sterile compounder for product quality concerns.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIApr 2, 2026
FDA inspection citations: Baxter Healthcare Corporation (9 observations)
FDA cites Baxter for sterility concerns; verify your sources.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIMar 19, 2026
FDA inspection citations: PReye LLC (4 observations)
Med spas should check sourcing from PReye LLC after FDA findings.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFLMulti-topicMar 13, 2026
FL S1728: Licensure of Medical Spas
Proposed licensure for medical spas would enhance oversight and compliance.
What to do — members only.Become a member →LegiScanprimary source ↗ - CAUTIONFLScope of PracticeMar 13, 2026
FL H1429: Licensure of Medical Spas
New regulations for med spas on licensure and compliance.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingMar 11, 2026
FDA recall (Class II): Semaglutide, For Rx compounding use only, packaged in a) 1g, Ndc 84385-106-01; b) 5g, Ndc 84385-106-02; c) 10g, Ndc 843…
Important recall on compounded Semaglutide products affecting med spas.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CAUTIONFEDGLP-1 CompoundingMar 11, 2026
FDA recall (Class II): Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061, …
FDA recalls Tirzepatide Inj over sterility concerns; check your stock!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingMar 11, 2026
FDA recall (Class II): Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061, Ndc …
FDA recalls Tirzepatide injection over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingMar 11, 2026
FDA recall (Class II): Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061, …
FDA recalls compounded GLP-1 product over sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CAUTIONFEDGLP-1 CompoundingMar 11, 2026
FDA recall (Class II): Semaglutide, For Rx compounding use only, packaged in a) 1g, Ndc 84385-106-01; b) 5g, Ndc 84385-106-02; c) 10g, Ndc 843…
FDA recalls specific compounded GLP-1 products due to quality issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFEDGLP-1 CompoundingMar 11, 2026
FDA recall (Class II): Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061,…
FDA recalls Semaglutide for sterility issues—act now!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIMar 6, 2026
FDA inspection citations: Pharmaceutics International, Inc. (9 observations)
FDA cites compounding facility for sterility and quality concerns.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - CAUTIONINNATIONALMulti-topicMar 5, 2026
IN SB0282: Compounding drugs; registration of medical spas.
New regulations for medical spas in Indiana take effect in 2027.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIMar 5, 2026
FDA inspection citations: Sharp Sterile Manufacturing, LLC (6 observations)
FDA cites facility for sterilization and procedural issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORINMulti-topicMar 4, 2026
IN HB1358: Indiana department of health.
Bill focuses on public health rather than aesthetic practices.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 27, 2026
FDA inspection citations: Tan-Alize Kozmetik ve Temizlik Urunleri Sanayi ve Ticaret A.S. (7 observations)
FDA inspection reveals quality concerns for a facility supplying med spas.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 27, 2026
FDA inspection citations: Gallant Pet Inc (10 observations)
FDA inspection reveals sterility issues at Gallant Pet Inc.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 27, 2026
FDA inspection citations: Gasco Industrial Corp. (13 observations)
FDA cites facility for issues potentially affecting product quality.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIFeb 26, 2026
FDA inspection citations: CoreRX Inc. (7 observations)
FDA cites CoreRX Inc. for multiple quality control issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFeb 23, 2026
FDA / Federal Register Notice: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
New FDA notice may impact GLP-1 compounding practices at med spas.
What to do — members only.Become a member →Federal Registerprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 20, 2026
FDA inspection citations: Staska Pharmaceuticals, Inc. (3 observations)
FDA cites Staska Pharmaceuticals for quality and sterility issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIFeb 18, 2026
FDA inspection citations: Gilead Sciences, Inc. (7 observations)
FDA cites Gilead Sciences for sterility and quality control issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 13, 2026
FDA inspection citations: K.C. Pharmaceuticals, Inc (13 observations)
FDA cites K.C. Pharmaceuticals for sterility concerns.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 12, 2026
FDA inspection citations: Tropical Seas, Inc. (8 observations)
FDA cites Tropical Seas for multiple quality concerns.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORAZScope of PracticeFeb 10, 2026
AZ HB4047: Medical spas; licensure; regulation
New licensure requirements for med spas in Arizona.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 6, 2026
FDA inspection citations: Eugia Pharma Specialities Limited (11 observations)
FDA cites Eugia Pharma for serious sterility issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIFeb 6, 2026
FDA inspection citations: Alcami Carolinas Corporation (6 observations)
Check sourcing from Alcami Carolinas after FDA citations.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 5, 2026
FDA inspection citations: Ony Biotech, Inc. (3 observations)
FDA inspection raises concerns about drug quality at ONY Biotech.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIFeb 5, 2026
FDA inspection citations: Nice-Pak Products, LLC (4 observations)
FDA cites Nice-Pak Products for facility inspection issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORMSGLP-1 CompoundingFeb 3, 2026
MS SB2544: Mississippi Active Pharmaceutical Ingredient Quality Assurance Act; enact to impose certain provisions for compounding.
New regulations could impact drug compounding for med spas.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 3, 2026
FDA inspection citations: Iso-Tex Diagnostics, Inc. (5 observations)
FDA cites Iso-Tex Diagnostics for quality and sterility issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJan 30, 2026
FDA inspection citations: Hibrow Healthcare Private Limited (2 observations)
FDA cites facility for drug quality concerns; verify your suppliers.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIJan 30, 2026
FDA inspection citations: Element Materials Technology Oakland-Concord (6 observations)
FDA cites facility for quality issues impacting compounded products.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJan 29, 2026
FDA inspection citations: American Regent, Inc. (4 observations)
FDA inspection reveals citations at American Regent, Inc.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDAesthetic DevicesJan 28, 2026
FDA device recall (Class II): Brand Name: Leaseir Product Name: Leaseir Mhr Xcell Model/Catalog Number: Mhr 110-b Software Version: 1.5.0.0 Product D…
Leaseir MHR Xcell laser recalled for safety issues.
What to do — members only.Become a member →FDA Device Recallprimary source ↗ - MONITORMAMulti-topicJan 27, 2026
MA H5087: Regulating the operation of medical spas
New regulations for med spas could redefine injector practices.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIJan 22, 2026
FDA inspection citations: Excel Vision (11 observations)
FDA cites Excel Vision for sterility and quality issues in inspection.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingJan 22, 2026
FDA inspection citations: Anika Therapeutics, Inc. (4 observations)
FDA cites Anika Therapeutics for quality and sterility issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORIAScope of PracticeJan 20, 2026
IA HSB591: A bill for an act establishing the medical spa oversight Act, and making penalties applicable.
New regulation may change operations for Iowa med spas.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJan 9, 2026
FDA inspection citations: OneBlood, Inc. (1 observation)
FDA cites OneBlood for sterile compounding issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingJan 7, 2026
FDA recall (Class II): Wegovy (Semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 B…
FDA recalls Wegovy due to safety concerns; med spas must act.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFEDGLP-1 CompoundingJan 7, 2026
FDA recall (Class II): Wegovy (Semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
FDA recalls Wegovy; med spas must check supplies!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJan 7, 2026
FDA inspection citations: South Bend Medical Foundation, Inc. (1 observation)
FDA cites facility for sterile preparation issues impacting compounding.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIDec 22, 2025
FDA inspection citations: Blaine Labs Inc (12 observations)
FDA cites Blaine Labs for quality issues; med spas should verify sourcing.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIDec 19, 2025
FDA inspection citations: International Medication Systems Ltd. (8 observations)
FDA cites facility for sterility issues affecting med spas.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIDec 17, 2025
FDA inspection citations: Wyeth Pharmaceutical Division of Wyeth Holdings LLC (4 observations)
FDA cites Wyeth for sterility issues; verify your sourcing.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORPAScope of PracticeDec 16, 2025
PA HB1881: Further providing for pharmacy technician and pharmacy technician trainee registration, qualifications and supervision; providing for administration of injectable medications, biologicals and immunizations, for clinical laboratory certificate and for report on pharmacy-administered vaccines; and making a repeal.
PA bill may expand pharmacy technicians' role in injectables.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIDec 11, 2025
FDA inspection citations: Nubratori, Inc (3 observations)
FDA cites Nubratori, Inc. for sterile drug production issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIDec 11, 2025
FDA inspection citations: Denver Solutions, LLC (7 observations)
FDA cites Denver Solutions for compliance issues impacting med spas.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIDec 11, 2025
FDA inspection citations: Life Science Outsourcing, Inc. (5 observations)
FDA cites facility for serious sterile product issues; verify sourcing.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIDec 10, 2025
FDA inspection citations: Medtronic, Inc. (2 observations)
Important FDA citations for a facility impacting med spas.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIDec 10, 2025
FDA inspection citations: Piramal Pharma Solutions Inc. (4 observations)
Med spas should verify sourcing from cited facility Piramal Pharma.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIDec 9, 2025
FDA inspection citations: Biomat USA Inc (4 observations)
FDA cites Biomat USA for critical sterile production issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIDec 5, 2025
FDA inspection citations: Ecolab LLC (2 observations)
FDA cites Ecolab for drug product quality concerns; check your sources.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIDec 4, 2025
FDA inspection citations: St Mary's Medical Park Pharmacy (7 observations)
FDA cites compounding pharmacy for numerous quality issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingNov 24, 2025
FDA / Federal Register Notice: Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
FDA seeks comments on human drug compounding practices.
What to do — members only.Become a member →Federal Registerprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAINov 21, 2025
FDA inspection citations: Sato Pharmaceutical Co., Ltd. (10 observations)
FDA cites Sato Pharmaceutical for quality concerns.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAINov 21, 2025
FDA inspection citations: Eagle Analytical Services, Inc. (4 observations)
Check sourcing from Eagle Analytical for sterile product compliance.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAINov 12, 2025
FDA inspection citations: Fordoz Pharma Co. (9 observations)
FDA cites Fordoz Pharma for sterile product issues; check your supply.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAINov 7, 2025
FDA inspection citations: Alliance Medical Products, Inc. (4 observations)
FDA cites facility for critical sterile product quality issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeff…
FDA recalls GLP-1 injection over sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 J…
FDA recalls Semaglutide injection due to sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingNov 5, 2025
FDA recall (Class II): Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeff…
Urgent FDA recall of Tirzepatide Injection impacts med spas.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAINov 5, 2025
FDA inspection citations: Fresenius Kabi Compounding, LLC (7 observations)
FDA cites compounding facility for quality and sterility issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 J…
FDA recalls Semaglutide injection due to sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Je…
FDA recalls Semaglutide injection over sterility issues; take action!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jef…
FDA recalls GLP-1 product; take immediate action.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CAUTIONFEDGLP-1 CompoundingNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jef…
Urgent: FDA recalls compounded semaglutide injection.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAINov 4, 2025
FDA inspection citations: Grand River Aseptic Manufacturing, Inc. (2 observations)
FDA cites Grand River Aseptic for concerns; verify your sourcing.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAINov 3, 2025
FDA inspection citations: Jubilant HollisterStier General Partnership (9 observations)
FDA cites facility for sterile drug production deficiencies.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIOct 20, 2025
FDA inspection citations: Par Health USA, LLC (4 observations)
FDA cites Par Health USA for serious sterile drug observations.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORPAScope of PracticeOct 17, 2025
PA SB1055: Further providing for pharmacy technician and pharmacy technician trainee registration, qualifications and supervision; providing for administration of injectable medications, biologicals and immunizations, for clinical laboratory certificate and for report on pharmacy-administered vaccines; and making a repeal.
PA's SB1055 could change injectable practice for pharmacy techs.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingOct 15, 2025
FDA recall (Class II): Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations, GenoGenix, LLC, 2840 Nw 2nd Ave Ste 20…
Important FDA recall on GLP-1 compounded product—act now!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingOct 15, 2025
FDA recall (Class II): Semaglutide for Injection, a) 20 mg b) 20 mg/mL, 10 mL Multi-Dose Vials, GenoGenix, LLC, 2840 Nw 2nd Ave Ste 204 Boca R…
FDA recalls semaglutide over sterility issues; check your stock!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingOct 15, 2025
FDA recall (Class II): Semaglutide with B12 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 Nw 2nd Ave Ste 204 Boca Raton…
FDA recalls GLP-1 product over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAISep 26, 2025
FDA inspection citations: Alcami Carolinas Corporation (3 observations)
FDA cites Alcami facility for quality control issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAISep 19, 2025
FDA inspection citations: Barbara Ann Karmanos Cancer Hospital (3 observations)
FDA cites Karmanos Cancer Hospital for sterility and QA issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAISep 19, 2025
FDA inspection citations: Actavis Laboratories Ut, Inc. (4 observations)
FDA cites facility for sterility issues impacting compounded products.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingSep 10, 2025
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
Urgent: GLP-1 injection recall for med spas sourcing compounded products.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingSep 10, 2025
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
Med spas must act on the GLP-1 product recall now!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFEDGLP-1 CompoundingSep 10, 2025
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
FDA recalls compounded GLP-1 product for being subpotent.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAISep 5, 2025
FDA inspection citations: North American Custom Laboratories, LLC DBA FarmaKeio Superior Custom Compounding (1 observation)
FDA cites compounding facility for sterility issues; verify sources.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIAug 29, 2025
FDA inspection citations: Bio-Medical Pharmaceutical Manufacturing Corporation (9 observations)
FDA cites facility for issues affecting product quality and sterility.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIAug 22, 2025
FDA inspection citations: Nephron Sc, LLC (6 observations)
FDA cites Nephron SC for sterile drug production issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIAug 22, 2025
FDA inspection citations: Lonza Tampa LLC (9 observations)
FDA cites Lonza Tampa for multiple quality control issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIAug 15, 2025
FDA inspection citations: United Laboratories Manufacturing, LLC (8 observations)
FDA cites facility for quality issues; check your source!
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - CRITICALFEDGLP-1 CompoundingAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, …
Important recall for GLP-1 products; take immediate action.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, …
FDA recalls compounded GLP-1 product due to processing controls issue.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFEDGLP-1 CompoundingAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
FDA recalls compounded GLP-1 product; check your stock now!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
Important FDA recall for compounded GLP-1 product impacts med spas.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile,…
FDA recalls compounded GLP-1 product over safety issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
Important recall for compounded GLP-1 products impacts med spas.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
FDA recalls compounded GLP-1 product due to safety concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
FDA recalls a GLP-1 product; check your supply immediately.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
Important recall of GLP-1 compounded product—act now!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
Ongoing recall of compounded GLP-1 product: take action now.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 13, 2025
FDA recall (Class II): Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile…
FDA recalls compounded GLP-1 product; take immediate action!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) s…
Stay informed: GLP-1 injectable recall may affect your practice.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
Alert: GLP-1 product recall due to processing issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIAug 12, 2025
FDA inspection citations: Fareva Morton Grove, Inc. (7 observations)
FDA cites concerns at Fareva Morton Grove; check your product sources.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIAug 8, 2025
FDA inspection citations: Steri-Pharma, LLC (3 observations)
FDA cites Steri-Pharma for quality concerns; verify your sources.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJul 31, 2025
FDA inspection citations: Cardinal Health 414, LLC (5 observations)
FDA cites Cardinal Health for sterility and quality issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJul 31, 2025
FDA inspection citations: Telix IsoTherapeutics Group, Inc. (10 observations)
FDA cites Telix for multiple sterile production issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingJul 30, 2025
FDA / Federal Register Notice: Outsourcing Facility Fee Rates for Fiscal Year 2026
New FDA fees for outsourcing facilities impact compounding.
What to do — members only.Become a member →Federal Registerprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIJul 28, 2025
FDA inspection citations: Doh Central Pharmacy (6 observations)
FDA cites DOH Central Pharmacy for quality and sterility issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJul 24, 2025
FDA inspection citations: North American Science Associates, LLC (1 observation)
FDA inspection raises concerns over product sterility.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIJul 18, 2025
FDA inspection citations: Right Value Drug Stores LLC (5 observations)
Inspecting citations may impact med spa sources for injectables.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIJul 16, 2025
FDA inspection citations: Bso LLC (9 observations)
FDA cites BSO LLC for concerns impacting sterile drug quality.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJul 15, 2025
FDA inspection citations: Biomat Holdings Mount Vernon Newark (1 observation)
FDA cites facility for contamination issues; verify your sources.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingJul 2, 2025
FDA recall (Class II): Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Su…
FDA recalls compounded GLP-1 product for sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingJul 2, 2025
FDA recall (Class II): Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
FDA recalls Tirzepatide due to sterility concerns - take action now!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingJul 2, 2025
FDA recall (Class II): Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-filled syringe, Thrive Health Solutions, 88 …
FDA recalls GLP-1 product due to sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingJul 2, 2025
FDA recall (Class II): Tirzepatide/Cyanocobalamin Injectable, 15mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, S…
Recall alert: Check your GLP-1 injectable supplies now!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFEDGLP-1 CompoundingJul 2, 2025
FDA recall (Class II): Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
FDA recalls Tirzepatide injections; action needed now.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingJul 2, 2025
FDA recall (Class II): Tirzepatide Injections, 20mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
FDA recalls Tirzepatide for sterility issues; take action now.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFEDGLP-1 CompoundingJul 2, 2025
FDA recall (Class II): Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, Co 80…
FDA recalls GLP-1 product over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingJul 2, 2025
FDA recall (Class II): Semaglutide, 5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, Co 80112
FDA recalls compounded GLP-1 product over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORRIScope of PracticeJun 30, 2025
RI S0976: Mandates cosmetic medical procedures be performed by a physician, PA, APRN, or delegated to a qualified non-physician, non-PA or non-APRN under the supervision of a physician, physician assistant, or advanced practice registered nurse.
New RI law mandates supervision for cosmetic procedures
What to do — members only.Become a member →LegiScanprimary source ↗ - CAUTIONRINATIONALScope of PracticeJun 30, 2025
RI H5351: Mandates cosmetic medical procedures be performed by a physician, PA, APRN, or delegated to a qualified non-physician, non-PA or non-APRN under the supervision of a physician, physician assistant, or advanced practice registered nurse.
Major changes in who can perform cosmetic procedures in RI med spas.
What to do — members only.Become a member →LegiScanprimary source ↗ - CRITICALFEDGLP-1 CompoundingMay 7, 2025
FDA recall (Class II): Wegovy (Semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx …
Urgent recall of Wegovy due to temperature abuse risks.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CAUTIONCOScope of PracticeApr 7, 2025
CO HB1024: Medical-Aesthetic Services Delegation Disclosures
New disclosure requirements for delegating medical-aesthetic services.
What to do — members only.Become a member →LegiScanprimary source ↗ - CAUTIONMSGLP-1 CompoundingFeb 13, 2025
MS HB1430: Prescription drugs; prohibit licensing boards from prohibiting practitioners from prescribing for off-label use.
Potential changes in off-label prescribing regulations in Mississippi.
What to do — members only.Become a member →LegiScanprimary source ↗